Citations (64)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Ya-Ming Xie, Wenfeng Lu, Jian Cheng, Mugen Dai, Si-Yu Liu, Dong-Dong Wang, Tian-Wei Fu, Tai-Wei Ye, Jun-Wei Liu, Cheng-Wu Zhang, Dong-Sheng Huang & Lei Liang. (2023) Naples Prognostic Score is an Independent Prognostic Factor in Patients Undergoing Hepatectomy for Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma 10, pages 1423-1433.
Read now
Read now
Ji-Feng Feng, Jian-Ming Zhao, Sheng Chen & Qi-Xun Chen. (2021) Prognostic Significance of the Lung Immune Prognostic Index in Patients with Resected Esophageal Squamous Cell Carcinoma. Cancer Management and Research 13, pages 2811-2819.
Read now
Read now
Wenhui Liu, Yiping Liu, Fang Ma, Bao Sun, Ying Wang, Jianquan Luo, Mouze Liu & Zhiying Luo. (2021) Peripheral Blood Markers Associated with Immune-Related Adverse Effects in Patients Who Had Advanced Non-Small Cell Lung Cancer Treated with PD-1 Inhibitors. Cancer Management and Research 13, pages 765-771.
Read now
Read now
Huanwei Liang, Huajian Peng & Long Chen. (2021) Prognostic Value of Sarcopenia and Systemic Inflammation Markers in Patients Undergoing Definitive Radiotherapy for Esophageal Cancer. Cancer Management and Research 13, pages 181-192.
Read now
Read now
Shao-Jun Xu, Guo-Sheng Lin, Hong-Jian Ling, Ren-Jie Guo, Jie Chen, Yi-Ming Liao, Tao Lin & Yong-Jian Zhou. (2020) Nomogram to Predict Preoperative Occult Peritoneal Metastasis of Gastrointestinal Stromal Tumors (GIST) Based on Imaging and Inflammatory Indexes. Cancer Management and Research 12, pages 11713-11721.
Read now
Read now
Guoxin Cai, Jinming Yu & Xue Meng. (2020) Predicting Prognosis and Adverse Events by Hematologic Markers in Patients with Locally Advanced Esophageal Squamous Cell Carcinoma Treated with Neoadjuvant Chemoradiotherapy. Cancer Management and Research 12, pages 8497-8507.
Read now
Read now
Aijie Li, Xiangkui Mu, Kewen He, Peiliang Wang, Duoying Wang, Chao Liu & Jinming Yu. (2020) Prognostic value of lymphocyte-to-monocyte ratio and systemic immune-inflammation index in non-small-cell lung cancer patients with brain metastases. Future Oncology 16:30, pages 2433-2444.
Read now
Read now
Jiao Hu, Yu Cui, Peihua Liu, Xu Zhou, Wenbiao Ren, Jinbo Chen & Xiongbing Zu. (2019) Predictors of inguinal lymph node metastasis in penile cancer patients: a meta-analysis of retrospective studies. Cancer Management and Research 11, pages 6425-6441.
Read now
Read now
Guangyan Cheng, Fei Liu, Xinyu Niu & Qigen Fang. (2019) Role of the pretreatment neutrophil-to-lymphocyte ratio in the survival of primary parotid cancer patients. Cancer Management and Research 11, pages 2281-2286.
Read now
Read now
Articles from other publishers (55)
Xin-Wei Guo, Lei Ji, Xiao-Xiang Xi, Wei-Wei Zhao, Yang-Chen Liu, Shao-Bing Zhou & Sheng-Jun Ji. (2024) Predictive potential of preoperative Naples prognostic score-based nomogram model for the prognosis in surgical resected thoracic esophageal squamous cell carcinoma patients: A retrospective cohort study. Medicine 103:18, pages e38038.
Crossref
Crossref
Guo-yue Zhang, Xian-zhi Du, Rui Xu, Ting Chen, Yue Wu, Xiao-juan Wu & Shui Liu. (2024) Development and Validation of a Machine Learning–Based Model Using CT Radiomics for Predicting Immune Checkpoint Inhibitor-related Pneumonitis in Patients With NSCLC Receiving Anti-PD1 Immunotherapy: A Multicenter Retrospective Case Control Study. Academic Radiology 31:5, pages 2128-2143.
Crossref
Crossref
Ruiya Ma, Yoshinaga Okugawa, Tadanobu Shimura, Shinji Yamashita, Yuhki Sato, Chengzeng Yin, Ryo Uratani, Takahito Kitajima, Hiroki Imaoka, Mikio Kawamura, Yuhki Morimoto, Yoshiki Okita, Shigeyuki Yoshiyama, Masaki Ohi & Yuji Toiyama. (2024) Clinical implications of C-reactive protein–albumin–lymphocyte (CALLY) index in patients with esophageal cancer. Surgical Oncology 53, pages 102044.
Crossref
Crossref
Ning Wu, Yang Song, Yongjun Zhu, Liewen Pang, Zhiming Chen & Xiaofeng Chen. (2024) Rad51 and Systemic Inflammatory Indicators as Novel Prognostic Markers in Esophageal Squamous Cell Carcinoma. Technology in Cancer Research & Treatment 23.
Crossref
Crossref
Yuxin Yang, Zhichao Liu, Chao Jiang, Jie Pan, Boyao Yu, Kaiyuan Zhu, Yunhua Xu & Zhigang Li. (2023) Prognostic Value of Combination of Lymphocyte‐to‐Monocyte‐Ratio and CYFRA 21‐1 in Esophageal Squamous Cell Carcinoma. World Journal of Surgery 47:12, pages 3240-3249.
Crossref
Crossref
Chun-Chun Huang, Le-Qian Ying, Yan-Ping Chen, Min Ji, Lu Zhang & Lin Liu. (2023) Metachronous primary esophageal squamous cell carcinoma and duodenal adenocarcinoma: A case report and review of literature. World Journal of Gastrointestinal Surgery 15:11, pages 2627-2638.
Crossref
Crossref
Chao Yang, Jian XuJie Wang, Zhiqiang Li & Qiong Yao. (2023) Prognostic value of platelet-to-basophil ratio (PBR) in patients with primary glioblastoma. Medicine 102:30, pages e34506.
Crossref
Crossref
Zhao Mu, Xiao Tang, Jingting Wang, Yulin Chen, Kui Cui, Xingyu Rao, Juan Li & Guodong Yang. (2023) Construction and external validation of a nomogram model for predicting the risk of esophageal stricture after endoscopic submucosal dissection: a multicenter case–control study. BMC Gastroenterology 23:1.
Crossref
Crossref
Wei‐Xiang Qi, Xiaoyan Wang, Chengqiang Li, Shuyan Li, Huan Li, Feifei Xu, Jiayi Chen, Shengguang Zhao & Hecheng Li. (2023) Pretreatment absolute lymphocyte count is an independent predictor for survival outcomes for esophageal squamous cell carcinoma patients treated with neoadjuvant chemoradiotherapy and pembrolizumab: An analysis from a prospective cohort. Thoracic Cancer 14:17, pages 1556-1566.
Crossref
Crossref
Mengying Li, Guoxin Cai, Zhenhua Gao, Xue Meng & Xiao Han. (2023) Inflammatory biomarkers as predictors of immune activation to different irradiated sites and short-term efficacy in advanced squamous cell esophageal carcinoma received radioimmunotherapy. Frontiers in Oncology 13.
Crossref
Crossref
Lijun SunPeng WeiShuang GeJie ZhengShucheng YeYanhui Zhang. (2023) A nomogram based on hematological markers to predict radiosensitivity in patients with esophageal squamous cell carcinoma. Medicine 102:11, pages e33282.
Crossref
Crossref
Hui-Ke Wang, Qian Wei, Ya-Lan Yang, Tai-Ying Lu, Yan Yan & Feng Wang. (2023) Clinical usefulness of the lymphocyte-to-monocyte ratio and aggregate index of systemic inflammation in patients with esophageal cancer: a retrospective cohort study. Cancer Cell International 23:1.
Crossref
Crossref
Rongyang Li, Bing Huang, Hui Tian & Zhenguo Sun. (2023) Immune evasion in esophageal squamous cell cancer: From the perspective of tumor microenvironment. Frontiers in Oncology 12.
Crossref
Crossref
Adem Bora. (2023) Is the neutrophil-to-lymphocyte ratio a marker for differentiating between benign and malignant submandibular gland masses?. Revista da Associação Médica Brasileira 69:11.
Crossref
Crossref
Zhengfeng Zhang, Lei Yang, Dazhen Wang, Yuli Ruan, Jianji Zhang, Lu Zhao, Liu Yang & Changjie Lou. (2023) Retrospective study of the combination of TP and PF regimens with or without immune checkpoint inhibitors for the first-line treatment of locally advanced or advanced esophageal squamous cell carcinoma. Therapeutic Advances in Medical Oncology 15, pages 175883592311699.
Crossref
Crossref
Fan Chen, Min Chao, Tao Huang, Shaochun Guo, Yulong Zhai, Yuan Wang, Na Wang, Xuan Xie, Liang Wang & Peigang Ji. (2022) The role of preoperative inflammatory markers in patients with central nervous system tumors, focus on glioma. Frontiers in Oncology 12.
Crossref
Crossref
Jin Zhou, Hai-Ping Lin, Xin Xu, Xiao-Hang Wang, Ling Rong, Yao Zhang, Lei Shen, Lei Xu, Wei-Ting Qin, Qing Ye, Xiu-Mei Ma & Yong-Rui Bai. (2022) The predictive value of peripheral blood cells and lymphocyte subsets in oesophageal squamous cell cancer patients with neoadjuvant chemoradiotherapy. Frontiers in Immunology 13.
Crossref
Crossref
J.-J. Ran, J.-J. Shen, J. Ma & X.-Y. Li. (2022) Survival analysis of 80 elderly patients with esophageal squamous cell carcinoma receiving definitive concurrent chemoradiotherapy with S-1. Cancer/Radiothérapie 26:8, pages 1064-1069.
Crossref
Crossref
Linlin Liang, Fangfang Liu, Zhonghu He & Yang Ke. (2022) ASO Author Reflections: A Novel Blood-Based Predictor (MF-A) That Independently Influences the Prognosis of ESCC Patients Receiving Esophagectomy. Annals of Surgical Oncology 29:9, pages 5634-5635.
Crossref
Crossref
Linlin Liang, Fangfang Liu, Wenlei Yang, Wei Yang, Lei Chen, Yu He, Zhen Liu, Liqun Zhang, Fan Zhang, Fen Cai, Huawen Xu, Miaoping Lin, Mengfei Liu, Yaqi Pan, Ying Liu, Zhe Hu, Huanyu Chen, Zhonghu He & Yang Ke. (2022) Combined Mean Corpuscular Hemoglobin, Fibrinogen, and Albumin (MF-A) Is a Novel Prognostic Marker in Patients with Resectable Esophageal Squamous Cell Carcinoma. Annals of Surgical Oncology 29:9, pages 5626-5633.
Crossref
Crossref
Xiaoqu Li, Shuhao Zhang, Juan Lu, Chao Li & Naibin Li. (2022) The prognostic value of systemic immune-inflammation index in surgical esophageal cancer patients: An updated meta-analysis. Frontiers in Surgery 9.
Crossref
Crossref
Haiyang Hu, Jun Zhang, Hang Yan, Chao Qin, Haiyang Guo, Tao Liu, Shengjie Tang & Haining Zhou. (2022) Development and validation of a novel prognostic model for patients with surgically resected esophageal squamous cell carcinoma. Frontiers in Oncology 12.
Crossref
Crossref
Keiko Ohkuwa, Kiminori Sugino, Ryohei Katoh, Mitsuji Nagahama, Wataru Kitagawa, Kenichi Matsuzu, Akifumi Suzuki, Chisato Tomoda, Kiyomi Hames, Junko Akaishi, Chie Masaki, Kana Yoshioka & Koichi Ito. (2022) Preoperative inflammatory markers for predicting parathyroid carcinoma. Endocrine Connections 11:7.
Crossref
Crossref
James Tankel, Alexander Calderone, Jose Luis Ramirez Garcia-Luna, Carmen L. Mueller, Sarah Najmeh, Jonathan Spicer, David Mulder, Lorenzo Ferri & Jonathan Cools-Lartigue. (2022) Changes in Perioperative Platelet Lymphocyte Ratio Predict Survival in Oesophago-Gastric Adenocarcinoma. Annals of Surgical Oncology 29:7, pages 4512-4519.
Crossref
Crossref
Huiru Xu, Huijing Feng, Weihong Zhang, Feng Wei, Li Zhou, Liang Liu, Yu Zhao, Yingge Lv, Xiuhuan Shi, Junping Zhang & Xiubao Ren. (2022) Prediction of immune-related adverse events in non-small cell lung cancer patients treated with immune checkpoint inhibitors based on clinical and hematological markers: Real-world evidence. Experimental Cell Research 416:1, pages 113157.
Crossref
Crossref
Cong Jiang, Shiyuan Zhang, Kun Qiao, Yuting Xiu, Xiao Yu & Yuanxi Huang. (2022) The Pretreatment Systemic Inflammation Response Index as a Useful Prognostic Factor is Better Than Lymphocyte to Monocyte Ratio in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy. Clinical Breast Cancer 22:5, pages 424-438.
Crossref
Crossref
Shuyue Zheng, Beilei Liu & Xinyuan Guan. (2022) The Role of Tumor Microenvironment in Invasion and Metastasis of Esophageal Squamous Cell Carcinoma. Frontiers in Oncology 12.
Crossref
Crossref
Chao Yang, Tian Lan, Yi Wang, Wen-Hong Huang, Si-Man Li, Jie Li, Feng-Ping Li, Yi-Rong Li, Ze-Fen Wang & Zhi-Qiang Li. (2022) Cumulative Scoring Systems and Nomograms for Predicating Survival in Patients With Glioblastomas: A Study Based on Peripheral Inflammatory Markers. Frontiers in Oncology 12.
Crossref
Crossref
Pasawat Supanimitjaroenporn, Virat Kirtsreesakul, Manupol Tangthongkum, Peesit Leelasawatsuk & Usaporn Prapaisit. (2022) Prognostic value of pretreatment lymphocyte‐to‐monocyte ratio in patients with advanced oral cavity cancer. Laryngoscope Investigative Otolaryngology 7:3, pages 740-745.
Crossref
Crossref
Na Liu, Jinmei Mao, Peizhi Tao, Hao Chi, Wenhui Jia & Chunling Dong. (2022) The relationship between NLR/PLR/LMR levels and survival prognosis in patients with non-small cell lung carcinoma treated with immune checkpoint inhibitors. Medicine 101:3, pages e28617.
Crossref
Crossref
Xu Chen, Qinghua Wang & Chengbin Li. (2022) A Retrospective Analysis of Hematologic Parameters in Patients with Early Diabetic Kidney Disease. Clinical and Applied Thrombosis/Hemostasis 28, pages 107602962210836.
Crossref
Crossref
Ji Feng Feng, Liang Wang, Qi-Xun Chen & Xun Yang. (2022) Development and Validation of a New Integrative Score Based on Various Systemic Inflammatory and Nutritional Indicators in Predicting Prognosis in Patients With Resectable Esophageal Squamous Cell Carcinoma: A Retrospective Cohort Study. Cancer Control 29, pages 107327482210913.
Crossref
Crossref
Jinhua Cai, Ruiqi Xue, Zongwei Yue, Zhan Zhang, Lei He, Honghong Li, Yi Li, Xiaoming Rong, Xiaoni Zhang, Yongteng Xu & Yamei Tang. (2022) Neutrophil to lymphocyte ratio as a predictor for treatment of radiation‐induced brain necrosis with bevacizumab in nasopharyngeal carcinoma patients. Clinical and Translational Medicine 12:1.
Crossref
Crossref
Kewei Zhao, Chunsheng Wang, Fang Shi, Yong Huang, Li Ma, Minghuan Li & Yipeng Song. (2021) Combined prognostic value of the SUVmax derived from FDG-PET and the lymphocyte-monocyte ratio in patients with stage IIIB-IV non-small cell lung cancer receiving chemotherapy. BMC Cancer 21:1.
Crossref
Crossref
Pei-Hsin Chen, Dah-Cherng YehHeng-Hsin Tung & Chin-Yao Lin. (2021) Prognostic and predictive factors of eribulin in patients with heavily pre-treated metastatic breast cancer. Medicine 100:47, pages e27859.
Crossref
Crossref
Yi Chen, Yi Yang, Xin-yuan Zhang, Qing-sheng Fan, Xiao Li, Yu-Jing Xin, Xiao-Jing Cao, Ya-Nan Wang & Xiang Zhou. (2021) Nomogram Based on Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio to Predict Recurrence in Patients with Hepatocellular Carcinoma after Radiofrequency Ablation. CardioVascular and Interventional Radiology 44:10, pages 1551-1560.
Crossref
Crossref
Yan Jiang, Dian Xu, Huan Song, Beibei Qiu, Dan Tian, Zhongqi Li, Ye Ji & Jianming Wang. (2021) Inflammation and nutrition-based biomarkers in the prognosis of oesophageal cancer: a systematic review and meta-analysis. BMJ Open 11:9, pages e048324.
Crossref
Crossref
Yusuke Ishibashi, Hironori Tsujimoto, Hidekazu Sugasawa, Keita Kouzu, Yujiro Itazaki, Takao Sugihara, Manabu Harada, Nozomi Ito, Yoji Kishi & Hideki Ueno. (2021) Prognostic value of platelet-related measures for overall survival in esophageal squamous cell carcinoma: A systematic review and meta-analysis. Critical Reviews in Oncology/Hematology 164, pages 103427.
Crossref
Crossref
Audrey E. Kam & Ashiq Masood. (2021) The Prognostic Role of the Neutrophil to Lymphocyte Ratio at Recurrence in Esophageal Squamous Cell Carcinoma: Challenges and Future Directions. Annals of Surgical Oncology 28:6, pages 2939-2940.
Crossref
Crossref
Jinnan Wu, Jinliang Chen, Xuedong Lv, Qichang Yang, Sumei Yao, Dongmei Zhang & Jianrong Chen. (2021) Clinical value of serum and exhaled breath condensate inflammatory factor IL-11 levels in non-small cell lung cancer: Clinical value of IL-11 in non-small cell lung cancer. The International Journal of Biological Markers 36:2, pages 64-76.
Crossref
Crossref
Ji-Feng Feng, Jian-Ming Zhao, Sheng Chen & Qi-Xun Chen. (2021) Naples Prognostic Score: A Novel Prognostic Score in Predicting Cancer-Specific Survival in Patients With Resected Esophageal Squamous Cell Carcinoma. Frontiers in Oncology 11.
Crossref
Crossref
Kele Cui, Shouxin Hu, Xinyu Mei & Min Cheng. (2021) Innate Immune Cells in the Esophageal Tumor Microenvironment. Frontiers in Immunology 12.
Crossref
Crossref
Jian-Bo Han, Qing-Hua Shu, Yu-Feng Zhang & Yong-Xiang Yi. (2021) Predictive Value of Inflammation Biomarkers in Patients with Portal Vein Thrombosis. Journal of Clinical and Translational Hepatology 000:000, pages 000-000.
Crossref
Crossref
Yonggang Zhang, Linli Zheng, Liuliu Quan & Liang Du. (2019) Prognostic role of platelet‐to‐lymphocyte ratio in oral cancer: A meta‐analysis. Journal of Oral Pathology & Medicine 50:3, pages 274-279.
Crossref
Crossref
Ming He, Zhan Qi, Rong Qiu, Yuanping Hu, Juan Li, Yuekao Li & Yuxiang Wang. (2021) Correlates of Long-Term Survival of Patients with pN+ Esophageal Squamous Cell Carcinoma after Esophagectomy. Journal of Oncology 2021, pages 1-10.
Crossref
Crossref
Chiara Offi, Roberto Maria Romano, Angelo Cangiano, Giancarlo Candela & Giovanni Docimo. (2021) Clinical significance of neutrophil-to-lymphocyte ratio, lymphocyte-to-monocyte ratio, platelet-to-lymphocyte ratio and prognostic nutritional index in low-risk differentiated thyroid carcinomaSignificato clinico del rapporto neutrofili/linfociti, rapporto linfociti/monociti, rapporto piastrine/linfociti e indice prognostico nutrizionale nei carcinomi differenziati della tiroide a basso rischio. Acta Otorhinolaryngologica Italica 41:1, pages 31-38.
Crossref
Crossref
Xue Zhang, Su LiJinhui Wang, Fubao Liu & Yong Zhao. (2021) Relationship Between Serum Inflammatory Factor Levels and Differentiated Thyroid Carcinoma. Technology in Cancer Research & Treatment 20, pages 153303382199005.
Crossref
Crossref
Gaoli Liu, Shaowen Zhang, Haifeng Hu, TingTing Liu & Jie Huang. (2020) The role of neutrophil-lymphocyte ratio and lymphocyte–monocyte ratio in the prognosis of type 2 diabetics with COVID-19. Scottish Medical Journal 65:4, pages 154-160.
Crossref
Crossref
Hongyu Jin, Man Zhang, Hui Zhou, Shiyu Zhu & Chenggong Hu. (2020) Survival and prognostic analysis of preoperative indicators in patients undergoing surgical resections with rhabdomyosarcoma. Medicine 99:43, pages e22760.
Crossref
Crossref
Jin-liang Chen, Jin-nan Wu, Xue-dong Lv, Qi-chang Yang, Jian-rong Chen & Dong-mei Zhang. (2020) The value of red blood cell distribution width, neutrophil-to-lymphocyte ratio, and hemoglobin-to-red blood cell distribution width ratio in the progression of non-small cell lung cancer. PLOS ONE 15:8, pages e0237947.
Crossref
Crossref
Na Zhang, Jianjun Jiang, Sihui Tang & Gengyun Sun. (2020) Predictive value of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in non-small cell lung cancer patients treated with immune checkpoint inhibitors: A meta-analysis. International Immunopharmacology 85, pages 106677.
Crossref
Crossref
Jidong Feng, Yanyan Wang, Guohui Shan & Lei Gao. (2020) Clinical and prognostic value of neutrophil-lymphocyte ratio for patients with thyroid cancer. Medicine 99:20, pages e19686.
Crossref
Crossref
Xiao-bo Liu, Zi-ye Gao, Qing-hui Zhang, Sandeep Pandey, Bo Gao, Fan Yang, Qiang Tong & Sheng-bao Li. (2020) Preoperative Neutrophil Lymphocyte Ratio Can Be Used as a Predictor of Prognosis in Patients With Adenocarcinoma of the Esophagogastric Junction: A Systematic Review and Meta Analysis. Frontiers in Oncology 10.
Crossref
Crossref
Yanfeng Wang, Enhao Liang, Xueke Zhao, Xin Song, Lidong Wang & Junwei Sun. (2020) Prediction of Survival Time of Patients With Esophageal Squamous Cell Carcinoma Based on Univariate Analysis and ASSA-BP Neural Network. IEEE Access 8, pages 181127-181136.
Crossref
Crossref
Yi Zhang & Bo Chen. (2019) Prognostic Value of the Advanced Lung Cancer Inflammation Index in Patients with Lung Cancer: A Meta-Analysis. Disease Markers 2019, pages 1-9.
Crossref
Crossref